CN Patent

CN110582489B — Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途

Assigned to Beijing Tide Pharmaceutical Co Ltd · Expires 2023-10-27 · 3y expired

What this patent protects

本发明涉及式(I)的Rho相关蛋白激酶抑制剂、包含其的药物组合物、其制备方法及其用于预防或治疗Rho相关蛋白激酶(ROCK)介导的疾病的用途。

USPTO Abstract

本发明涉及式(I)的Rho相关蛋白激酶抑制剂、包含其的药物组合物、其制备方法及其用于预防或治疗Rho相关蛋白激酶(ROCK)介导的疾病的用途。

Drugs covered by this patent

belumosudil-mesylate (BELUMOSUDIL MESYLATE)

Patent Metadata

Patent number: CN110582489B
Jurisdiction: CN
Classification: —
Expires: 2023-10-27
Drug substance claim: No
Drug product claim: No
Assignee: Beijing Tide Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.